Latham & Walkins advised Parsons in the offering, and Davis Polk & Wardwell advised the representatives of the initial purchasers. Parsons Corporation (NYSE: PSN) announced its offering...
You must be a Standard 1 Year member to access this content.
Latham & Watkins has advised Goldman Sachs, Morgan Stanley, CICC, and J.P. Morgan, as initial purchasers. NIO Inc. has completed the offering of US$500 million in aggregate...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Live Nation Entertainment in the offering. Live Nation Entertainment, Inc. (NYSE: LYV) has announced the completion of its previously announced offering...
You must be a Standard 1 Year member to access this content.
Latham & Watkins and Conyers represented Marti Technologies Inc. in the transaction. Willkie Farr & Gallagher represented Galata. White & Case represented B. Riley Securities. Galata Acquisition...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented the initial purchasers in the offering. DigitalOcean Holdings, Inc. finalized its offering of US$1.5 billion aggregate principal amount of 0% convertible senior notes...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Vertical Aerospace on the deal. Vertical Aerospace Ltd. (“Vertical”), a global aerospace and technology company that is pioneering zero-emissions aviation, closed US$205...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Opendoor, while Davis Polk advised the representatives of the initial purchasers in the offering. Opendoor Technologies Inc. executed its offering of US$850 million aggregate...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised EQRx on the deal. EQRx closed a strategic drug creation, development, and commercialization collaboration with Exscientia. The collaboration combines Exscientia’s leading AI-driven drug...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented the initial purchasers in the offering. Haemonetics Corporation (NYSE: HAE) priced its offering of US$435 million aggregate principal amount of 0% Convertible...
You must be a Standard 1 Year member to access this content.
